Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | Combo: DNA & protein vaccines |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Follow up complete |
| Study Start Date: | 2014-07-09 |
| Study Made Public: | NA |
Title
A Phase 1b clinical trial to evaluate the safety and immunogenicity of different combinations of DNA-HIV-PT123 and AIDSVAX B/E in healthy, HIV uninfected adult participants
Description
HVTN 105 is a Phase Ib clinical trial to evaluate the safety and immunogenicity of combinations of DNA-HIV-PT123 and AIDSVAX B/E.
Sign in to see full information about this study and to download study data.
Products
AIDSVAX B/E DNA-HIV-PT123 Saline (NaCl)Integrated data
BAMA, ICS, NAb
Non-integrated data
No non-integrated data is available for this study.